These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 54744)

  • 21. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors.
    Lubbe WF; Podzuweit T; Opie LH
    J Am Coll Cardiol; 1992 Jun; 19(7):1622-33. PubMed ID: 1350597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical training increases ventricular fibrillation thresholds of isolated rat hearts during normoxia, hypoxia and regional ischemia.
    Noakes TD; Higginson L; Opie LH
    Circulation; 1983 Jan; 67(1):24-30. PubMed ID: 6291806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade.
    Opie LH; Lubbe WF
    S Afr Med J; 1979 Nov; 56(22):871-80. PubMed ID: 42151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and prevention of ventricular fibrillation: are there better agents?
    Waller DG
    Resuscitation; 1991 Oct; 22(2):159-66. PubMed ID: 1684244
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
    Hellestrand KJ
    Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822
    [No Abstract]   [Full Text] [Related]  

  • 26. [The antifibrillatory properties of bonnecor].
    Grigor'eva EK; Gorbunova VV
    Farmakol Toksikol; 1990; 53(3):36-7. PubMed ID: 2387377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart.
    Lubbe WF; McFadyen ML; Muller CA; Worthington M; Opie LH
    Am J Cardiol; 1979 Mar; 43(3):533-40. PubMed ID: 217261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic actions of nifedipine in acute myocardial ischemia.
    Lubbe WF; McLean JA; Nguyen T
    Am Heart J; 1983 Feb; 105(2):331-3. PubMed ID: 6823819
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of cibenzoline on myocardial ischemia].
    Ohmi H; Hino T; Yamamoto K; Kamigaki M; Nakamura K; Ichihara K; Abiko Y
    Nihon Yakurigaku Zasshi; 1988 Nov; 92(5):325-35. PubMed ID: 3243514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
    Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH
    G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter: Cyclic A.M.P. and arrhythmias.
    de Gaetano G; Donati MB; Bonaccorsi A; Franco R; Dejana E; Buczko W
    Lancet; 1976 Apr; 1(7964):864. PubMed ID: 56686
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological agents to aid the clinician in combating myocardial ischaemia.
    Parratt JR
    Eur Heart J; 1983 Jul; 4 Suppl D():91-9. PubMed ID: 6137384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of myocardial cyclic AMP and vulnerability to fibrillation in the rat heart.
    Lubbe WF; Nguyen T; West EJ
    Fed Proc; 1983 May; 42(8):2460-4. PubMed ID: 6301887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of ethacizine and lidocaine to prevent ventricular fibrillation in acute myocardial infarction].
    Tsyganov OO
    Sov Med; 1988; (11):54-5. PubMed ID: 3238511
    [No Abstract]   [Full Text] [Related]  

  • 35. Critical role of dose in protection by propranolol against ventricular fibrillation in a pig model of acute myocardial ischemia.
    Muller CA; Opie LH; Peisach M; Pineda CA; Hamm CW; Thandroyen FT
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):192-7. PubMed ID: 2468945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic lidocaine in acute myocardial infarction: resurface or reburial?
    Yadav AV; Zipes DP
    Am J Cardiol; 2004 Sep; 94(5):606-8. PubMed ID: 15342291
    [No Abstract]   [Full Text] [Related]  

  • 37. Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine.
    Kertes P; Hunt D
    Br Heart J; 1984 Sep; 52(3):241-7. PubMed ID: 6380549
    [No Abstract]   [Full Text] [Related]  

  • 38. Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury.
    Wang S; Radhakrishnan J; Ayoub IM; Kolarova JD; Taglieri DM; Gazmuri RJ
    J Appl Physiol (1985); 2007 Jul; 103(1):55-65. PubMed ID: 17431086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reperfusion-induced ventricular fibrillation. Modification by pharmacological agents.
    Manning AS; Crome R; Isted K; Coltart DJ; Hearse DJ
    Adv Myocardiol; 1985; 6():515-28. PubMed ID: 2581300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-arrhythmic effects of myocardial ischaemia. Relation to reperfusion arrhythmias?
    Podzuweit T; Binz KH; Nennstiel P; Flaig W
    Cardiovasc Res; 1989 Feb; 23(2):81-90. PubMed ID: 2550132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.